GeoVax Labs Net Loss History
| GOVX Stock | USD 1.09 -0.06 -5.22% |
Net Loss | First Reported 2000-03-31 | Previous Quarter -4.4 M | Current Value -4.4 M | Quarterly Volatility 2.4 M |
Macro event markers
Latest GeoVax Labs Net Loss Growth Pattern
| Net Loss | 10 Years Trend |
|
Net Income |
| Timeline |
Net Loss Trend Statistics
GeoVax Labs reports Net Loss with a coefficient of variation of 215.7% over 15 periods, reflecting wide dispersion driven primarily by directional growth rather than instability. R-squared at 0.64 is consistent with a strong linear fit indicating consistent directional movement.| Arithmetic Mean | -6,717,246 | |
| Geometric Mean | 6,190,868 | |
| Coefficient Of Variation | -215.70 | |
| Mean Deviation | 10,006,815 | |
| Median | -2,733,555 | |
| Standard Deviation | 14,489,225 | |
| Sample Variance | 209.9T | |
| Range | 62.6M | |
| R-Value | -0.80 | |
| Mean Square Error | 80.2T | |
| R-Squared | 0.64 | |
| Significance | 0.0001 | |
| Slope | -2,299,129 | |
| Total Sum of Squares | 3359T |
GeoVax Labs Net Loss History
GeoVax Labs' Net Loss is tracked from 2012 through 2026, spanning 15 reported values, moving from -2.1 M to -20.4 M.| 2026 | -20.4 M | ||
| 2025 | -21.5 M | ||
| 2024 | -25 M | ||
| 2023 | -26 M | ||
| 2022 | -14 M | ||
| 2021 | -18.5 M | ||
| 2020 | -2.9 M | ||
| 2019 | -2.4 M | ||
| 2018 | -2.6 M | ||
| 2017 | -2.2 M | ||
| 2016 | -3.3 M | ||
| 2015 | -2.7 M | ||
| 2014 | -2.7 M | ||
| 2013 | -2.3 M | ||
| 2012 | -2.1 M |
Correlation of Net Loss With Other Accounts
Below are pairwise correlations of GeoVax Labs' Net Loss with other financial line items. Coefficients range from −1 (perfect inverse) to +1 (perfect co-movement). These values describe historical association and do not imply causation.Related Fundamentals
| Last Reported | End Of Year Estimate | ||
| Price To Sales Ratio | 1.65 | 1.57 | |
| Days Sales Outstanding | 69.99 | 118.79 | |
| Book Value Per Share | 4 M | 4.2 M | |
| Free Cash Flow Yield | -524.16% | -498.00% |
Methodology, Assumptions & Data Sources
The data below presents GeoVax Labs's Net Loss through recent fiscal years. Period-over-period changes in this line item trace to underlying business decisions visible in the financial statements. As a Biotechnology company, GeoVax Labs' Net Loss should be benchmarked against sector peers for meaningful interpretation.
Reported values for GeoVax Labs are derived from periodic company reporting and market reference feeds and standardized for analysis. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.
Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board